Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wayne, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Aclaris Therapeutics, Inc. has filed 849 SEC EDGAR filings since 10 Sep 2012

SEC filing history

Showing 701-725 of 849 matching filings.

Per page
25
Current page
29
4

PRIMARY DOCUMENT

Filing date
21 Dec 2016
Reporting date
19 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2016
Reporting date
18 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2016
Reporting date
18 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2016
Reporting date
18 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2016
Reporting date
18 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2016
Reporting date
18 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2016
Reporting date
15 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2016
Reporting date
15 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2016
Reporting date
15 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2016
Reporting date
15 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2016
Reporting date
15 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-212095

EFFECT filing

Filing date
01 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-212095

POS AM

Filing date
28 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89137

SC 13D/A

Filing date
21 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Nov 2016
Reporting date
16 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-212095

424B3

Filing date
18 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
18 Nov 2016
Reporting date
16 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214384

424B5

Filing date
18 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214384

424B5

Filing date
17 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-212095

424B3

Filing date
15 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
15 Nov 2016
Reporting date
15 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-214384

EFFECT filing

Filing date
14 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214384

424B5

Filing date
14 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .